Post-translational modifications: regulators of neurodegenerative proteinopathies
One of the hallmark features in the neurodegenerative disorders (NDDs) is the accumulation
of aggregated and/or non-functional protein in the cellular milieu. Post-translational …
of aggregated and/or non-functional protein in the cellular milieu. Post-translational …
Sound of silence: the properties and functions of repressive Lys methyltransferases
C Mozzetta, E Boyarchuk, J Pontis… - Nature Reviews Molecular …, 2015 - nature.com
The methylation of histone Lys residues by Lys methyltransferases (KMTs) regulates
chromatin organization and either activates or represses gene expression, depending on …
chromatin organization and either activates or represses gene expression, depending on …
How do post-translational modifications influence the pathomechanistic landscape of Huntington's disease? A comprehensive review
Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disorder
characterized by the loss of motor control and cognitive ability, which eventually leads to …
characterized by the loss of motor control and cognitive ability, which eventually leads to …
Epigenetic mechanism of SETDB1 in brain: implications for neuropsychiatric disorders
Y Zhu, D Sun, M Jakovcevski, Y Jiang - Translational Psychiatry, 2020 - nature.com
Neuropsychiatric disorders are a collective of cerebral conditions with a multifactorial and
polygenetic etiology. Dysregulation of epigenetic profiles in the brain is considered to play a …
polygenetic etiology. Dysregulation of epigenetic profiles in the brain is considered to play a …
AGO2 and SETDB1 cooperate in promoter-targeted transcriptional silencing of the androgen receptor gene
S Cho, JS Park, YK Kang - Nucleic acids research, 2014 - academic.oup.com
In mammals, RNA interference is primarily a post-transcriptional mechanism. Evidence has
accumulated for additional role in transcriptional gene silencing (TGS) but the question for a …
accumulated for additional role in transcriptional gene silencing (TGS) but the question for a …
Canonical Wnt signalling regulates nuclear export of Setdb1 during skeletal muscle terminal differentiation
S Beyer, J Pontis, E Schirwis, V Battisti, A Rudolf… - Cell Discovery, 2016 - nature.com
The histone 3 lysine 9 methyltransferase Setdb1 is essential for both stem cell pluripotency
and terminal differentiation of different cell types. To shed light on the roles of Setdb1 in …
and terminal differentiation of different cell types. To shed light on the roles of Setdb1 in …
Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease
Huntington's disease (HD) is a neurodegenerative disorder caused by a polyglutamine
expansion in the protein huntingtin (HTT)[55]. While the final pathological consequence of …
expansion in the protein huntingtin (HTT)[55]. While the final pathological consequence of …
Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease
Huntington's disease (HD) is an autosomal-dominant inherited neurological disorder caused
by expanded CAG repeats in exon 1 of the Huntingtin (HTT) gene. Altered histone …
by expanded CAG repeats in exon 1 of the Huntingtin (HTT) gene. Altered histone …
Protein UFMylation regulates early events during ribosomal DNA-damage response
P Panichnantakul, LC Aguilar, E Daynard, M Guest… - Cell Reports, 2024 - cell.com
The highly repetitive and transcriptionally active ribosomal DNA (rDNA) genes are
exceedingly susceptible to genotoxic stress. Induction of DNA double-strand breaks (DSBs) …
exceedingly susceptible to genotoxic stress. Induction of DNA double-strand breaks (DSBs) …
Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model
YJ Hwang, SJ Hyeon, Y Kim, S Lim… - Journal of enzyme …, 2021 - Taylor & Francis
The present study describes evaluation of epigenetic regulation by a small molecule as the
therapeutic potential for treatment of Huntington's disease (HD). We identified 5-allyloxy-2 …
therapeutic potential for treatment of Huntington's disease (HD). We identified 5-allyloxy-2 …